EMEA-001379-PIP01-12-M04

Key facts

Invented name
Sivextro
Active substance
Tedizolid (phosphate)
Therapeutic area
Infectious diseases
Decision number
P/0226/2019
PIP number
EMEA-001379-PIP01-12-M04
Pharmaceutical form(s)
  • Film-coated tablet
  • Powder for concentrate for solution for infusion
  • Powder for oral suspension
Condition(s) / indication(s)
Treatment of acute bacterial skin and skin structure infections
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe) Inc.
Tel. +33 180464738
E-mail: pip.information@merck.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating